TAL1 and T-cell leukemia: The potential TAL1 protein targets associated with the implementationof its transcriptional activity are considered as promising targets for the therapy ofTAL1-associated T-cellleukemia (Fig. 6).These proteins include UTX demethylase (also known as KDM6A).